Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: Insights from proteomics

Nov 22, 2013Proteomics. Clinical applications

Understanding brain cell loss in people with Down syndrome through protein analysis

AI simplified

Abstract

After age 40, most individuals with Down syndrome develop dementia resembling Alzheimer's disease.

  • Down syndrome is associated with neurodegeneration characterized by complex neuropathology.
  • Impaired mitochondrial function, increased oxidative stress, and altered protein management may contribute to neurodegeneration in Down syndrome.
  • Increased oxidative damage and accumulation of misfolded protein aggregates are critical to neurodegenerative processes.
  • Chronic oxidative stress in Down syndrome may accelerate cognitive and memory decline.
  • Changes in redox status in Down syndrome neurons could create conditions that promote neurodegeneration as individuals age.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • ๐Ÿ“š7 fresh studies
  • ๐Ÿ“plain-language summaries
  • โœ…direct links to original studies
  • ๐Ÿ…top journal indicators
  • ๐Ÿ“…weekly delivery
  • ๐Ÿง˜โ€โ™‚๏ธalways free